Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Homeless Shelters in Chicago, Illinois-March-May, 2020.

COVID-19 SARS-CoV-2 congregate settings homeless transmission

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 02 09 2020
accepted: 08 10 2020
entrez: 2 12 2020
pubmed: 3 12 2020
medline: 3 12 2020
Statut: epublish

Résumé

People experiencing homelessness are at increased risk of coronavirus disease 2019 (COVID-19), but little is known about specific risk factors for infection within homeless shelters. We performed widespread severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction testing and collected risk factor information at all homeless shelters in Chicago with at least 1 reported case of COVID-19 (n = 21). Multivariable, mixed-effects log-binomial models were built to estimate adjusted prevalence ratios (aPRs) for SARS-CoV-2 infection for both individual- and facility-level risk factors. During March 1 to May 1, 2020, 1717 shelter residents and staff were tested for SARS-CoV-2; 472 (27%) persons tested positive. Prevalence of infection was higher for residents (431 of 1435, 30%) than for staff (41 of 282, 15%) (prevalence ratio = 2.52; 95% confidence interval [CI], 1.78-3.58). The majority of residents with SARS-CoV-2 infection (293 of 406 with available information about symptoms, 72%) reported no symptoms at the time of specimen collection or within the following 2 weeks. Among residents, sharing a room with a large number of people was associated with increased likelihood of infection (aPR for sharing with >20 people compared with single rooms = 1.76; 95% CI, 1.11-2.80), and current smoking was associated with reduced likelihood of infection (aPR = 0.71; 95% CI, 0.60-0.85). At the facility level, a higher proportion of residents leaving and returning each day was associated with increased prevalence (aPR = 1.08; 95% CI, 1.01-1.16), whereas an increase in the number of private bathrooms was associated with reduced prevalence (aPR for 1 additional private bathroom per 100 people = 0.92; 95% CI, 0.87-0.98). We identified a high prevalence of SARS-CoV-2 infections in homeless shelters. Reducing the number of residents sharing dormitories might reduce the likelihood of SARS-CoV-2 infection. When community transmission is high, limiting movement of persons experiencing homelessness into and out of shelters might also be beneficial.

Sections du résumé

BACKGROUND BACKGROUND
People experiencing homelessness are at increased risk of coronavirus disease 2019 (COVID-19), but little is known about specific risk factors for infection within homeless shelters.
METHODS METHODS
We performed widespread severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction testing and collected risk factor information at all homeless shelters in Chicago with at least 1 reported case of COVID-19 (n = 21). Multivariable, mixed-effects log-binomial models were built to estimate adjusted prevalence ratios (aPRs) for SARS-CoV-2 infection for both individual- and facility-level risk factors.
RESULTS RESULTS
During March 1 to May 1, 2020, 1717 shelter residents and staff were tested for SARS-CoV-2; 472 (27%) persons tested positive. Prevalence of infection was higher for residents (431 of 1435, 30%) than for staff (41 of 282, 15%) (prevalence ratio = 2.52; 95% confidence interval [CI], 1.78-3.58). The majority of residents with SARS-CoV-2 infection (293 of 406 with available information about symptoms, 72%) reported no symptoms at the time of specimen collection or within the following 2 weeks. Among residents, sharing a room with a large number of people was associated with increased likelihood of infection (aPR for sharing with >20 people compared with single rooms = 1.76; 95% CI, 1.11-2.80), and current smoking was associated with reduced likelihood of infection (aPR = 0.71; 95% CI, 0.60-0.85). At the facility level, a higher proportion of residents leaving and returning each day was associated with increased prevalence (aPR = 1.08; 95% CI, 1.01-1.16), whereas an increase in the number of private bathrooms was associated with reduced prevalence (aPR for 1 additional private bathroom per 100 people = 0.92; 95% CI, 0.87-0.98).
CONCLUSIONS CONCLUSIONS
We identified a high prevalence of SARS-CoV-2 infections in homeless shelters. Reducing the number of residents sharing dormitories might reduce the likelihood of SARS-CoV-2 infection. When community transmission is high, limiting movement of persons experiencing homelessness into and out of shelters might also be beneficial.

Identifiants

pubmed: 33263069
doi: 10.1093/ofid/ofaa477
pii: ofaa477
pmc: PMC7665740
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofaa477

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Lancet Infect Dis. 2020 Jul;20(7):776-777
pubmed: 32224313
J Gen Intern Med. 2018 May;33(5):635-643
pubmed: 29185174
N Engl J Med. 2020 May 28;382(22):2158-2160
pubmed: 32329972
Nicotine Tob Res. 2019 Nov 19;21(12):1644-1651
pubmed: 30759252
Int J Tuberc Lung Dis. 2013 Nov;17(11):1414-9
pubmed: 24125444
JAMA Intern Med. 2013 Feb 11;173(3):189-95
pubmed: 23318302
J Infect. 2019 Nov;79(5):401-406
pubmed: 31465780
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):521-522
pubmed: 32352957
JAMA. 2020 Jun 2;323(21):2191-2192
pubmed: 32338732
Tob Induc Dis. 2020 Mar 20;18:20
pubmed: 32206052
Emerg Infect Dis. 2019 Jul;25(7):1408-1411
pubmed: 31211675
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
PLoS One. 2019 Jul 18;14(7):e0220204
pubmed: 31318967
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):523-526
pubmed: 32352954
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346
pubmed: 32214079
Occup Environ Med. 1998 Apr;55(4):272-7
pubmed: 9624282
Lancet. 2014 Oct 25;384(9953):1529-40
pubmed: 25390578
Nicotine Tob Res. 2020 Aug 24;22(9):1653-1656
pubmed: 32399563

Auteurs

Isaac Ghinai (I)

Chicago Department of Public Health, Chicago, Illinois, USA.
Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Elizabeth S Davis (ES)

Rush University Medical Center, Chicago, Illinois, USA.

Stockton Mayer (S)

University of Illinois at Chicago, Chicago, Illinois, USA.

Karrie-Ann Toews (KA)

Chicago Department of Public Health, Chicago, Illinois, USA.
Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Thomas D Huggett (TD)

Lawndale Christian Health Center, Chicago, Illinois, USA.

Nyssa Snow-Hill (N)

University of Illinois at Chicago, Chicago, Illinois, USA.

Omar Perez (O)

University of Illinois at Chicago, Chicago, Illinois, USA.

Mary K Hayden (MK)

Rush University Medical Center, Chicago, Illinois, USA.

Seena Tehrani (S)

Rush University Medical Center, Chicago, Illinois, USA.

A Justine Landi (AJ)

Rush University Medical Center, Chicago, Illinois, USA.

Stephanie Crane (S)

Rush University Medical Center, Chicago, Illinois, USA.

Elizabeth Bell (E)

Rush University Medical Center, Chicago, Illinois, USA.

Joy-Marie Hermes (JM)

Rush University Medical Center, Chicago, Illinois, USA.

Kush Desai (K)

Rush University Medical Center, Chicago, Illinois, USA.

Michelle Godbee (M)

Rush University Medical Center, Chicago, Illinois, USA.

Naman Jhaveri (N)

University of Illinois at Chicago, Chicago, Illinois, USA.

Brian Borah (B)

University of Illinois at Chicago, Chicago, Illinois, USA.

Tracy Cable (T)

University of Illinois at Chicago, Chicago, Illinois, USA.

Sofia Sami (S)

University of Illinois at Chicago, Chicago, Illinois, USA.

Laura Nozicka (L)

University of Illinois at Chicago, Chicago, Illinois, USA.

Yi-Shin Chang (YS)

University of Illinois at Chicago, Chicago, Illinois, USA.

Aditi Jagadish (A)

Chicago Department of Public Health, Chicago, Illinois, USA.
University of Illinois at Chicago, Chicago, Illinois, USA.

Mark Chee (M)

Chicago Department of Public Health, Chicago, Illinois, USA.
University of Chicago, Chicago, Illinois, USA.

Brynna Thigpen (B)

Chicago Department of Public Health, Chicago, Illinois, USA.

Christopher Llerena (C)

Chicago Department of Public Health, Chicago, Illinois, USA.
University of Illinois at Chicago, Chicago, Illinois, USA.

Minh Tran (M)

Chicago Department of Public Health, Chicago, Illinois, USA.
University of Illinois at Chicago, Chicago, Illinois, USA.

Divya Meher Surabhi (DM)

Chicago Department of Public Health, Chicago, Illinois, USA.
University of Illinois at Chicago, Chicago, Illinois, USA.

Emilia D Smith (ED)

Chicago Department of Public Health, Chicago, Illinois, USA.
University of Illinois at Chicago, Chicago, Illinois, USA.

Rosemary G Remus (RG)

Chicago Department of Public Health, Chicago, Illinois, USA.

Roweine Staszcuk (R)

Chicago Department of Public Health, Chicago, Illinois, USA.

Evelyn Figueroa (E)

University of Illinois at Chicago, Chicago, Illinois, USA.

Paul Leo (P)

University of Illinois at Chicago, Chicago, Illinois, USA.

Wayne M Detmer (WM)

Lawndale Christian Health Center, Chicago, Illinois, USA.

Evan Lyon (E)

Heartland Alliance Health, Chicago, Illinois, USA.

Sarah Carreon (S)

PCC Wellness, Chicago, Illinois, USA.

Stacey Hoferka (S)

Illinois Department of Public Health, Springfield, Illinois, USA.

Kathleen A Ritger (KA)

Chicago Department of Public Health, Chicago, Illinois, USA.

Wilnise Jasmin (W)

Chicago Department of Public Health, Chicago, Illinois, USA.

Prathima Nagireddy (P)

Chicago Department of Public Health, Chicago, Illinois, USA.

Jennifer Y Seo (JY)

Chicago Department of Public Health, Chicago, Illinois, USA.

Marielle J Fricchione (MJ)

Chicago Department of Public Health, Chicago, Illinois, USA.

Janna L Kerins (JL)

Chicago Department of Public Health, Chicago, Illinois, USA.

Stephanie R Black (SR)

Chicago Department of Public Health, Chicago, Illinois, USA.

Lisa Morrison Butler (LM)

Chicago Department of Family & Support Services, Chicago, Illinois, USA.

Kimberly Howard (K)

Chicago Department of Family & Support Services, Chicago, Illinois, USA.

Maura McCauley (M)

Chicago Department of Family & Support Services, Chicago, Illinois, USA.

Todd Fraley (T)

Chicago Department of Public Health, Chicago, Illinois, USA.

M Allison Arwady (MA)

Chicago Department of Public Health, Chicago, Illinois, USA.

Stephanie Gretsch (S)

Chicago Department of Public Health, Chicago, Illinois, USA.

Megan Cunningham (M)

Chicago Department of Public Health, Chicago, Illinois, USA.

Massimo Pacilli (M)

Chicago Department of Public Health, Chicago, Illinois, USA.

Peter S Ruestow (PS)

Chicago Department of Public Health, Chicago, Illinois, USA.

Emily Mosites (E)

Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Elizabeth Avery (E)

Rush University Medical Center, Chicago, Illinois, USA.

Joshua Longcoy (J)

Rush University Medical Center, Chicago, Illinois, USA.

Elizabeth B Lynch (EB)

Rush University Medical Center, Chicago, Illinois, USA.

Jennifer E Layden (JE)

Chicago Department of Public Health, Chicago, Illinois, USA.

Classifications MeSH